Quick Listen: Scrip’s Five Must-Know Things

 
• By Ian Haydock

In this week's episode: semaglutide in 2027 Medicare price negotiations; J&J expects revenue growth despite challenges; Roche’s China Accelerator makes progress; Scrip Asks about the impact of political change; and Datroway’s US approval in breast cancer.

Scrip Five Must Know Things
weekly audio roundup of selected content from Scrip's global team

More from Scrip's Five Must-Know Things

More from Business